The largest database of trusted experimental protocols

20 protocols using vismodegib

1

Conditional Notch1 Activation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gt(ROSA)26Sortm1(Notch1)Dam/J (Rosa26-NICD1) mice, B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J (Rosa26-EYFP) mice, B6.129S-Atoh1tm4.1Hzo/J (Math1M1GFP) mice, B6.Cg-Tg(Atoh1-cre)1Bfri/J (Math1-Cre) transgenic mice, and C57BL/6 mice (all from Jackson Laboratory, Bar Harbor, ME), and Tg(Lmx1a-cre)1Kjmi (Lmx1a-Cre) transgenic mice were maintained by breeding with C57BL/6 mice. Experimental procedures on animals housed at Sanford Research were approved by Sanford Research Institutional Animal Care and Use Committee and performed in compliance with national regulatory standards. No statistical method was used to predetermine sample size in animal experiments. The animal experiments were not randomized. The investigators were not blinded to group allocation during experiments and outcome assessment. Experimental animals were administered 100 mg/kg vismodegib (LC laboratories, Woburn, MA, V-4050) or vehicle following two regimens: daily treatment from day E15.5 through E18.5 (Mcre;NICD1 mice: 10 animals for each treatment); or from day E17.5 through day P7 (Lcre;NICD1 mice: 29 animals for vismodegib, 26 animals for vehicle), by gastric gavage of pregnant or nursing females.
+ Open protocol
+ Expand
2

Conditional Notch1 Activation in Mice

Check if the same lab product or an alternative is used in the 5 most similar protocols
Gt(ROSA)26Sortm1(Notch1)Dam/J (Rosa26-NICD1) mice, B6.129X1-Gt(ROSA)26Sortm1(EYFP)Cos/J (Rosa26-EYFP) mice, B6.129S-Atoh1tm4.1Hzo/J (Math1M1GFP) mice, B6.Cg-Tg(Atoh1-cre)1Bfri/J (Math1-Cre) transgenic mice, and C57BL/6 mice (all from Jackson Laboratory, Bar Harbor, ME), and Tg(Lmx1a-cre)1Kjmi (Lmx1a-Cre) transgenic mice were maintained by breeding with C57BL/6 mice. Experimental procedures on animals housed at Sanford Research were approved by Sanford Research Institutional Animal Care and Use Committee and performed in compliance with national regulatory standards. No statistical method was used to predetermine sample size in animal experiments. The animal experiments were not randomized. The investigators were not blinded to group allocation during experiments and outcome assessment. Experimental animals were administered 100 mg/kg vismodegib (LC laboratories, Woburn, MA, V-4050) or vehicle following two regimens: daily treatment from day E15.5 through E18.5 (Mcre;NICD1 mice: 10 animals for each treatment); or from day E17.5 through day P7 (Lcre;NICD1 mice: 29 animals for vismodegib, 26 animals for vehicle), by gastric gavage of pregnant or nursing females.
+ Open protocol
+ Expand
3

Hedgehog Pathway Regulation in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
DAOY cells (American Type Culture Collection, ATCC, Manassas, VA, USA) were grown as described previously [38 (link)]. BSZ2 cells were grown as described in [40 (link)] and PANC-1 (ATCC) cells as described in [46 (link)].
Ptch−/− and Sufu−/− embryonic fibroblasts were grown in DMEM supplemented with 10% fetal bovine serum (FBS), antibiotics and for Sufu−/−cells also with L-glutamine. During assays and treatments of confluent cells, FBS was reduced to 0.5%. For 3-dimensional (3D) cultures, 5 × 103 cells were seeded in 12-well plates as described previously [62 (link)]. 3D spheroid cultures were grown for 4-6 weeks at 37°C in a humidified atmosphere containing 5% CO2. Colony formation was documented on a stereomicroscope with Cell^D Image capture system (Olympus, Tokyo, Japan) and quantified using Colony Counter Software (Microtec Nition, Chiba, Japan). Smoothened agonist SAG (Axxora, Farmingdale NY, USA), harmine (Thermo Fisher Scientific, Waltham, MA, USA), vismodegib, cyclopamine (LC Laboratories, Woburn, MA, USA), GANT61 (Merck Chemicals Ltd., Darmstadt, Germany) and DYRKi were dissolved in dimethylsulfoxide (DMSO, Sigma, St. Louis, MO, USA).
+ Open protocol
+ Expand
4

Endoneurial Fibroblast Proliferation Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
Endoneurial fibroblasts were cultured on coverslips in a 12 well plate and grown to confluency. After reaching approximately 70% confluency, cells were treated with SAG21k (10nM) or Vismodegib (LC Laboratories Cat. # V-4050) (25nM) in complete MEM. EdU staining kit (Click-iT™ EdU Imaging Kit, ThermoFisher) and Ki67 antibody staining was used to assess proliferation of endoneurial fibroblasts. Cells were fixed at 0, 6, 24 and 48 hours after treatment. EdU positive cells were counted using ImageJ and compared to total cell count to determine the percentage of proliferation. The average number of Ki67 was counted. In addition, Ki67 positive cells compared to total cell count was determined. Representative images using x10 magnification are shown while cell counts for Edu and Ki67 was performed by taking tile scan images.
+ Open protocol
+ Expand
5

Small Molecule Inhibitor Preparation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The small molecule inhibitor 13-197 was provided by Dr. Amarnath Natarajan (University of Nebraska Medical Center). Hedgehog inhibitor vismodegib was purchased from LC laboratories (Woburn, MA) and PLK1 inhibitor BI2536 and chemotherapy topotecan were purchased from Selleckchem Company (Houston TX). These inhibitors were dissolved in DMSO at appropriate concentrations and stored at −20°C.
+ Open protocol
+ Expand
6

Investigation of Drug Classes Effects

Check if the same lab product or an alternative is used in the 5 most similar protocols
We investigated several drug classes, including: TKIs (n = 26), cyclin dependent kinase inhibitors (n = 2; alvocidib and palbociclib), Hedgehog signaling inhibitor (n = 1; vismodegib) and proteasome inhibitors (n = 2; bortezomib and carfilzomib), all purchased from LC Laboratories (Woburn, MA) (Suppl. Table 2). The compounds were solubilized in DMSO (250 µM for alvocidib, bortezomib and carfilzomib; 20 mM for vandetanib, 25 mM for all others) and stored frozen at −80°C.
+ Open protocol
+ Expand
7

Inhibition of Th17 Cell Differentiation

Check if the same lab product or an alternative is used in the 5 most similar protocols
CD4+ T cells were treated with the Smo inhibitors cyclopamine (Alfa Aesar, cat no. J61528; 25 mg) or vismodegib (LC Laboratories, cat no. V-4050) at the concentrations indicated. Stock solutions were prepared in DMSO (Life Technologies) for vismodegib and ethanol for cyclopamine at 10 mM and diluted to working concentration in complete IMDM (Gibco). vismodegib stocks were prepared from fresh vials and used within a week.
CD4+ T cells were treated with the selective STAT3 inhibitor STATTIC (Bio-Techne, cat no. 2798) and TGFβ signaling inhibitor SB-505124 (Sigma, cat no. S4696) during Th17 polarization. In order to block extracellular Ihh ligand the monoclonal Hh blocking antibody (clone: 5E1, 2BScientific, cat no. Ab01175) or mouse IgG control antibody (Biolegend, cat no. 400370) was used. To block TGFβ signaling, 10 μg/ml anti-TGFβ blocking antibody (clone: 1D11, R&D Systems, cat no. MAB1835) was used.
+ Open protocol
+ Expand
8

Inhibitor Dissolution and Storage

Check if the same lab product or an alternative is used in the 5 most similar protocols
The HH inhibitor Vismodegib and PI3K-mTOR dual inhibitor BEZ235 were purchased from LC laboratories (Woburn, MA) and a chemotherapeutic drug, cisplatin was purchased from Selleckchem Company (Houston TX). These inhibitors were dissolved in DMSO at appropriate concentrations and stored at −20°C.
+ Open protocol
+ Expand
9

Vismodegib Impacts Taste Bud Structure

Check if the same lab product or an alternative is used in the 5 most similar protocols
All animal care and experimental procedures followed U.S. National Institutes of Health guidelines and were approved by the Animal Care and Use Committee of the National Institute on Aging. Male C57BL/6J mice (Jackson Laboratory, Bar Harbor, ME) were administered by daily oral gavage of 30 mg/kg vismodegib (LC Laboratories, Woburn, MA) in 0.5% methylcellulose and 0.2% Tween 80 (MCT) 34 (link). Animals of both vehicle and vismodegib groups were euthanized after 15 weeks of treatment using isoflurane overdose and tongues were collected from each animal. The length of the study was to allow for at least four taste cell turnovers. Tongues were fixed in 10% neutral-buffered formalin (Sigma-Aldrich, St Louis, MO) for 1 h and then cryoprotected with 20% sucrose in 0.1 mol/L phosphate buffer overnight at 4°C. Serial sections (8–10 μm thickness) were cut through circumvallate papillae using a cryostat (HM 500M, MICRON, GmbH, Germany). In order to obtain a systematic appreciation without bias of the entire papillae, each papilla was sectioned and every 10th section was saved onto a slide. As taste buds are approximately 80–100 μm in length, sampling every 10th section ensured that no two sections were from the same taste bud.
+ Open protocol
+ Expand
10

Gastric and Pancreatic Cancer Cell Culture Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
AGS and MKN-45 are Lauren diffuse-type gastric adenocarcinoma cell lines, and NCI-N87 (subsequently referred to as N87) is a Lauren intestinal-type gastric adenocarcinoma cell line. These cells were obtained from the America Type Culture Collection (ATCC, Manassas, VA). CFPAC-1 and PANC-1 are pancreatic adenocarcinoma cell lines and were also obtained from ATCC. Cell lines were maintained in Dulbecco modified Eagle medium (DMEM) supplemented with 10% fetal bovine serum, 100 U/mL penicillin and 100 μg/ml streptomycin, and L-glutamine 2 mM (“regular media”). Cancer cell lines were actively passaged for less than 6 months from the time that they were received from ATCC, and UKCCCR guidelines were followed (14 (link)). Vismodegib was purchased from LC Laboratories (Woburn, MA). 5-fluorouracil was purchased from US Biological. Cisplatin was purchased from Enzo Life Sciences (Farmingdale, NY).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!